Saturday, 29th January 2022
<To guardian.ng
Search

US pharma firm Moderna says its COVID-19 vaccine is 94.5% effective

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.

Related

14 Feb 2021
The EU's vaccine rollout has come under fire for its slow pace amid production shortages. BioNTech-Pfizer now plans on supplying around 2 billion total doses, up from a previous 1.3 billion, by the end of 2021.
21 Feb 2021
According to German media outlets, in June the companies offered 500 million doses for €27 billion. The head of German Drug Commission suspects "profiteering."
13 Mar 2021
The EU will receive an extra four million BioNTech/Pfizer doses over the next two weeks to douse virus "hotspots", European Commission chief Ursula von der Leyen says.
19 Mar 2021
EU chief Ursula von der Leyen says expediting 10 million doses will give Member States "room to maneuver," after several EU countries halted the use of the AstraZeneca shot.
26 Apr 2021
Brussels says its third contract with the US-German vaccine consortium is the world's largest supply deal so far to stem the coronavirus' spread.
6 May 2021
The FDA is expected to approve the BioNTech-Pfizer COVID-19 vaccine for adolescents between the ages of 12 and 15 next week, according to media reports. DW has the latest.
12 May 2021
The German-developed coronavirus vaccine has become the first to get the go ahead for use among children aged 12 and up.
13 May 2021
The CDC has given a green light to using the BioNTech-Pfizer vaccine in children aged 12 to 15. Meanwhile, Cuba has started inoculating its citizens using two locally produced vaccines. Follow DW for the latest.
10 Jun 2021
President Joe Biden is expected to make the announcement before the G7 summit kicks off. The donation comes as the US attempts to reclaim its role as a global leader after four years of isolationism.
25 Jun 2021
The US Centers for Disease Control and prevention have confirmed that myocarditis and pericarditis can occur after mRNA vaccination in young people. But the cases are rare. Medical experts still recommend the shots.
13 Jul 2021
BioNTech and Pfizer said an extra dose of their jab could boost immunity against the coronavirus delta variant. South Korea raised pandemic restrictions as cases hit the "maximum crisis level." Follow DW for the latest.
23 Jul 2021
The Biovac Institute reached a deal with Pfizer to prepare and deliver vaccine doses for the continent. It comes amid an increase of cases in Africa, where just 2% of the population have received a first dose.